Array ( [0] => acquisition [1] => acquisition-policy [2] => all-news [3] => budget [4] => congress [5] => contractsawards [6] => government-shutdown [7] => management [8] => radio-interviews [9] => workforce )

Free drugs and the Economy

This week on BGOV’s Capital Impact show hosted by Allen Scott:

  • The Affordable Care Act (ACA) may provide a big boost in drug benefits to many “safety-net” hospitals even as the number of uninsured patients served by those facilities declines. Senior Health-Care Analyst Brian Rye discusses the pros and cons in his latest Bloomberg Government Analysis, The 340B Conundrum, on this weeks Capital Impact.
  • As things return to what is considered normal on Capitol Hill, the job numbers are released to provide a glimpse into how the economy was performing pre-shutdown. They don’t look good and all indicators are the post shut-down numbers won’t be any better. What does that mean for the economy? Bloomberg Government Senior Economic Analyst Dr. Nela Richardson joins the program and provides some insight and explains what the nomination of Janet Yellen does for the Federal Reserve>.

(Links above require a subscription to


Allen Scott (moderator) specializes in customer on boarding and training at Bloomberg Government. Allen previously worked at Arbitron, Inc. where he served in a variety of roles from customer service to sales operations manager. Prior to Arbitron, Allen worked in radio for several years in the Washington and Baltimore areas. Most recently he spent six years at 99.1 HFS as co-host and news director.
Brian Rye is a health care financial analyst with Bloomberg Government. Before joining Bloomberg, he spent 12 years as an equity research analyst at SunTrust, Raymond James and Janney Montgomery Scott. In those capacities, he followed biotech, pharmaceutical and other health care companies. Rye also served as a senior business management analyst for Booz Allen Hamilton’s civil health group. He received a bachelor’s degree in economics from Vanderbilt University and holds the Chartered Financial Analyst designation.
Nela Richardson is an economic analyst with Bloomberg Government. She was a research economist at the Commodity Futures Trading Commission before joining Bloomberg. Richardson was also a senior economist at Freddie Mac, a researcher at Harvard’s Joint Center for Housing Studies, and an adjunct professor of finance at Johns Hopkins. Richardson has a Ph.D. in economics from the University of Maryland, a M.A. from the University of Pennsylvania, and a B.A. from Indiana University.